Download
1 / 6
60 likes | 72 Vues
The Heparin Market report research highlights key dynamics of the global sector. The potential of the industry has been investigated along with the key challenges. The current market scenario and prospects of the sector has also been studied.
E N D
Heparin Market Size, Growth Trends, Top Players, Application Potential and Forecast to 2028 © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com
Global Market Scenario of Heparin Model • Global Market Insights recently introduced report on global Heparin Market report is an in-depth study providing complete analysis of the industry for the period 2022 to 2028. It provides complete overview of the industry considering all the major industry trends, market dynamics and competitive scenario. • Heparin market growth is expected to be progressive over 2022-2028 on grounds of the growing geriatric population worldwide and rising prevalence of cardiovascular diseases. As per CDC statistics, 14.2% of people aged 45 years and above in the U.S. are reported to be suffering from coronary heart disease. • Heparin is a blood thinning drug that prevents the formation of blood clots caused by certain medical conditions or procedures. It is also used before a surgery to reduce the risk of blood clots. Overall, the heparin industry is classified into different segments including product, source, applications, distribution channel, and the regional landscape. © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com
Continue:- • Browse key industry insights spread across 140 pages with 237 market data tables & 18 figures & charts from the report, “Heparin Market Analysis By Product (Low Molecular Weight Heparin, Unfractionated Heparin), Source (Porcine, Bovine), Application (Venous Thromboembolism, Atrial Fibrillation/Flutter, Coronary Artery Disease), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Industry Analysis Report, Regional Outlook, Price Trends, Application Potential, Competitive Market Share & Forecast, 2022 – 2028” in detail along with the table of contents: • https://www.gminsights.com/industry-analysis/heparin-market © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com
360° Industry Analysis • In terms of the product segment, the market is bifurcated in low molecular weight heparin and unfractionated heparin. Of these two, the unfractionated heparin market segment is projected to foresee a valuation of $663.5 million by 2028 globally, backed by the drug's increasing use against venous thromboembolism, a condition where blood clots develop in veins. • Based on the source, heparin industry is divided into porcine and bovine segments. The market share from bovine sector, amongst these, would be worth $56.9 million over the foreseeable timeline. Bovine-based heparin products are extensively used in cardiovascular surgery to alleviate the risks of blood clot during the procedure. • Speaking of applications, the heparin therapy is utilized in coronary artery disease, venous thromboembolism, atrial fibrillation, and others. The coronary artery disease segment was worth $1,117.9 million in 2021 subject to the mounting prevalence of CAD worldwide. CDC statistics suggest that approximately 18.2 million adults aged 20 and older suffer from the disease in the U.S. alone. The use of heparin in acute coronary syndrome is to reduce the progression of intracoronary thrombus and prevent myocardial infarction and fatality. © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com
Competitive Analysis: • Amphastar • Leo Pharma • Pfizer • Rovi • Sanofi • Shenzhen Hepalink • Browse Complete Summary of this report @https://www.gminsights.com/industry-analysis/heparin-market © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com
Stay In Touch You can visit us at: www.gminsights.com Thank You…! © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com
